SOBI to acquire Pint Pharma International from Farallon Capital-backed Pintador.

Synopsis

SOBI, a biopharmaceutical and biotechnology company, agreed to acquire Pint Pharma International, a biopharmaceutical company, from Farallon Capital-backed Pintador, a holding company. Financial terms were not disclosed.

Principals

target

Pint Pharma International

bidder

Swedish Orphan Biovitrum (sobi)

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context